Cemex's Record Q2 Looks Good-But $42M Europe Win, Demand Gaps, and Cash Conversion Decide the Stock

Q2 Results Raised the Bar for Cemex

Cemex delivered record second-quarter EBITDA of $1.018 billion, ahead of the consensus average of $937.4 million, and raised its full-year EBITDA growth outlook to 16% to 17% from the prior high-single-digit range. That kind of guide-up after a strong quarter shifts the debate: the question is no longer whether Cemex improved, but whether the improvement is durable enough to justify a higher valuation.

Why bulls see operating leverage

Management highlighted 24% EBITDA growth, EBITDA margin expanded by 2.1 percentage points to 22.2%, and Free Cash Flow from Operations tripled year-over-year, reaching US$637 million. Those gains came alongside Project Cutting Edge efficiencies and organic growth in most regions, strengthening the case that Cemex is building real operating leverage rather than relying on a one-off rebound.

Why bears focus on the Europe settlement

The quarter also included a favorable one-time settlement in Europe totaling $42 million. Adjusting for that benefit, sales rose 11%, EBITDA increased 19% and EBIT grew 29%. The underlying business improved materially, but not as dramatically as the headline EBITDA figure alone might suggest.

What matters now

With guidance raised, Cemex now has less room for disappointment. The key test is whether the transformation is broad enough to support 16% to 17% full-year EBITDA growth, not just whether it can produce one standout quarter.

Cemex's Improvement Looks Real, but Still Selective

Even after removing the $42 million one-time settlement in Europe, Cemex still reported 11% consolidated sales growth, 19% EBITDA growth, and 29% EBIT growth. That points to a healthier operating model, but not necessarily to a fully uniform recovery.

Regional performance supports the improvement

Sales grew in all four regions, and Cemex said Mexico delivered solid results supported by cost efficiencies, demand improvements (and) operating leverage. That broad-based top-line movement, combined with margin expansion, argues against the idea that only one part of the business improved.

But demand recovery still appears uneven

In the first quarter, adverse weather in the U.S. and Europe weighed on activity, and Cemex leaned on cement volume recovery in Mexico and disciplined pricing to support results. The Q2 update strengthened the overall performance story, but it did not clearly erase that regional split. Adjusted and reported EBITDA margins now sit in a 21.4% to 22.2% range, which shows leverage is working. Still, leverage can come from pricing and cost control even before every market fully participates in the recovery.

That is the central distinction here. The evidence supports operating leverage and better execution, but it still looks more accurate to describe the business as selectively strong rather than uniformly recovered.

Cash Conversion Matters More Than EBITDA Now

Once guidance is raised, investors tend to care less about effort and more about whether earnings turn into cash.

Cemex already posted strong cash flow

The company reported Free Cash Flow from Operations of $637 million, and management also cited a second-quarter record free cash flow from operations of $651 million. That is an important signal because it shows improvement is reaching the cash statement, not just EBITDA.

Why the market will focus on conversion next

EBITDA shows the operating engine is healthier. Cash conversion shows how much of that improvement can support debt reduction, shareholder returns, or reinvestment. If Cemex can keep turning earnings into cash while holding the new guide, the stock has a stronger case to re-rate.

The next watchpoint

Management also said it sees a potential US$300 million opportunity in free cash flow from lower growth capital expenditures, reduced intangible investments, and maintenance spending aligned with best-in-class performance. If future quarters show the same discipline, credibility should improve further.

Cemex Is a Watchlist Candidate, Not a Blind Chase

Tactically, this setup improves only if Cemex keeps converting gains from Project Cutting Edge efficiencies and organic growth in most regions into cash, while investors look past the favorable one-time settlement in Europe and focus on the larger 2027 opportunity.

The base case

The thesis gets stronger if Cemex can show that the post-settlement improvement was not a one-quarter phenomenon, with sales increased un 11% and broad contribution across all four regions.

Why 2027 matters

Cemex has already lifted its savings target to US$475 million, says 80% of the original target already achieved, and indicated that the majority of the new savings expected to be realized in 2027. That makes 2027 the more important window for execution and potential multiple expansion.

What would weaken the thesis

The outlook becomes less compelling if EBITDA keeps beating while cash generation softens, or if future results rely more heavily on one-time benefits rather than sustained operating improvement. For now, the best read is a stronger quarter with real progress, but not yet a fully proven broad recovery.